IHS FormWeb
Approved Formulary
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
IHS FormWeb
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted Medications
Renal Adjustment Policy
Therapeutic Interchange Policy
Hazard.Drug Handling(USP 800)
Hazardous Waste
Chemotherapy
IV to PO Conversion Policy
Black Box Warnings
Look-Alike/Sound-Alike
REMS
Staff Telephone Numbers
Webpage Links
Search results for:
voriconazole IV
voriconazole IV
Brand names:
Vfend
Form
Strength
POWDER FOR INJECTION, INTRAVENOUS
200 mg
Display
Azoles
Class:
081408
Medication comments:
voriconazole should be dosed using
Adjusted Body Weight
for obese patients with BMI >30 kg/m
2
.
IV Push Guidelines
Renal Adjust
IV to PO
Haz.Handle
Per policy, these drugs are subject to renal dosing adjustments by pharmacy.
Renal Dosing Program
View all
Generic + Route
(Brand)
• Indications
Usual Adult Dose
Comments
Renal Dosage Adjustments
voriconazole
IV
(
Vfend
©
)
6 mg/kg q12h x 2 doses, then 3-4 mg/kg q12h
No adjustment necessary
Per policy, these drugs may be converted from IV to PO in patients who meet criteria.
View all
voriconazole
(Vfend) IV
weight based dosing (3-4 mg/kg q12h)
200 mg PO q12h
fixed (non-weight based) dosing
may convert from IV to PO on a mg-to-mg basis.
USP <800> Hazardous Drug Assessment of Risk (AOR)
View all
Per policy, these drugs are exempt from USP <800> handling requirements under normal circumstances.
The following outlines must be followed.
generic (Brand) Route [Packaging: Manufacturer ⇒ Dispense]
NIOSH Group
voriconazole (Vfend)
IV
[n/a]
Reproductive Risk
Pharmacy:
Receiving /
Storage /
Preparation
Exposure Risk:
low
• Handling/preparation PPE Requirements: Double
CX gloves
,
gown
,
CSTD
• Receiving from Distributor: Standard
• Pharmacy Storage Area: IV
CSTD
Area
• Packaging/Reconstitution Location: n/a
• Compounding (Non-Sterile/Sterile) Location:
Ideal:
Positive pressure room
Required:
Med Prep Area with Immediate Use Preparation standards
• Omnicell Load: No
Transport
• Transport (dose is placed inside a plastic sealable bag): Double bag, single
CX gloves
Nursing:
Storage /
Admin.
Exposure Risk:
low
• Handling/administration PPE Requirements: Single CX glove,
gown
, use of
CSTD
• Storage of Finished dose in Nursing Area/Procedural Area: Picked up from Pharmacy
• Signage on Patient Door Required: Yes
• Manipulation of Dosage Form: n/a
• Special Manipulation for Administration: n/a
Disposal /
Spills
• Disposal of Drug Waste: Full-
black bin
, trace-
yellow bin
• Disposol of Used PPE:
yellow bin
• Spill management: Manage like antineoplastic agents
Reason for exemption of USP<800> Containment Requirements:
Preg Category D. Release to the environment should be minimized per MSDS.
Last updated:
Apr. 4, 2024
Renal Adjustment Policy
voriconazole subject to adjustments by pharmacy.
Hazard.Drug Handling(USP 800)
USP<800> Hazardous Drug / Assessment of Risk
IV to PO Conversion Policy
Policy
UpToDate
FDA DailyMed Package Insert
MedLinePlus (Patient Information)
MSDS Online
(Brand)
• Indications
Comments
(Vfend©)
(Vfend) IV
The following outlines must be followed.
Receiving /
Storage /
Preparation
low
Required: Med Prep Area with Immediate Use Preparation standards
Storage /
Admin.
low
Spills